Ascend Wellness Holdings (AAWH) EBT (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly EBT came in at -$17.6 million in Q1 2026, down 113.76% year-on-year from $127.8 million in Q1 2025, and up 45.83% quarter-over-quarter from -$32.5 million in Q4 2025.
Ascend Wellness Holdings (AAWH) EBT (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' EBT history runs 7 years deep, the most recent figure standing at -$17.6 million for Q1 2026.
- On a quarterly basis, EBT fell 113.76% year-over-year to -$17.6 million in Q1 2026; TTM through Mar 2026 was -$76.2 million, a 79.67% decrease from a year earlier, with the FY2025 full-year figure at -$66.8 million, down 67.78% from the prior year.
- EBT grew to -$17.6 million in Q1 2026 per AAWH's latest filing, from -$32.5 million in the prior quarter.
- Across five years, EBT topped out at $5.6 million in Q2 2023 and bottomed at -$32.5 million in Q4 2025.
- The 5-year median for EBT is -$8.5 million (2023), against an average of -$10.5 million.
- Across the five-year window, EBT plunged 690.54% in 2022 and surged 157.51% in 2023, its largest moves.
- Year by year, EBT stood at -$3.1 million in 2022, then plunged by 136.64% to -$7.4 million in 2023, then climbed by 18.55% to -$6.0 million in 2024, then plunged by 440.92% to -$32.5 million in 2025, then soared by 45.83% to -$17.6 million in 2026.
- Per Business Quant, the three latest AAWH EBT figures stand at -$17.6 million (Q1 2026), -$32.5 million (Q4 2025), and -$13.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 318.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | -17.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.59 Mn |
| Dec 31, 2025 | -32.47 Mn |
| Sep 30, 2025 | -13.55 Mn |
| Jun 30, 2025 | -12.58 Mn |
| Mar 31, 2025 | -8.23 Mn |
| Dec 31, 2024 | -6.00 Mn |
| Sep 30, 2024 | -18.49 Mn |
| Jun 30, 2024 | -9.68 Mn |
| Mar 31, 2024 | -5.65 Mn |
| Dec 31, 2023 | -7.37 Mn |
| Sep 30, 2023 | -4.51 Mn |
| Jun 30, 2023 | 5.58 Mn |
| Mar 31, 2023 | -8.46 Mn |
| Dec 31, 2022 | -3.11 Mn |
| Sep 30, 2022 | -5.68 Mn |
| Jun 30, 2022 | -9.70 Mn |
| Mar 31, 2022 | -20.71 Mn |
| Dec 31, 2021 | -8.07 Mn |
| Sep 30, 2021 | -719,000.00 |
| Jun 30, 2021 | -32.90 Mn |